ResMed Inc. (RMD) is a publicly traded Healthcare sector company. As of August 8, 2026, RMD trades at $214.00 with a market cap of $32.38B and a P/E ratio of 20.18. RMD moved -5.06% today. Year to date, RMD is -13.43%; over the trailing twelve months it is -24.35%. Its 52-week range spans $180.27 to $293.81. Analyst consensus is buy with an average price target of $242.30. Rallies surfaces RMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ResMed Inc. (RMD) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RMD moved -5.06% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $214.00 |
| Market Cap | $32.38B |
| P/E Ratio | 20.18 |
| EPS | $10.41 |
| Dividend Yield | 0.66% |
| 52-Week High | $293.81 |
| 52-Week Low | $180.27 |
| Volume | 3.43M |
| Avg Volume | 0 |
| Revenue (TTM) | $5.54B |
| Net Income | $1.52B |
| Gross Margin | 61.59% |
12 analysts cover RMD: 0 strong buy, 4 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $242.30.